Clinical Trials Logo

Clinical Trial Summary

This study aims to investigate the efficacy and safety of Bronchial Thermoplasty on moderate bronchial asthma in China, by observing the improvement of quality of life, the decrease of acute attack and emergence, as well as the incidence of related complications.


Clinical Trial Description

This is a multi-center, open-label and single arm study. At least 50 patients with moderate asthma receive Bronchial Thermoplasty for three times. Asthma Quality of Life Questionnaire (AQLQ), Asthma Control Questionnaire (ACQ), Frequency of mild asthma acute attack, PEF, FEV1, Emergency and Hospitalization are compared between before and after BT treatment.

The unified peak flow test meter will be provided to all subjects enrolled in this study. They will get a follow-up diary book before leaving hospital. In order to ensure the efficiency, all enrolled asthma patients are trained and tested by doctors and nurses from in-patient or out-patient department when they follow up, including how to use the PEF meter, how to read and record the data. As for the dosage of medication, all the medication uses are followed the doctor's advice, once the rescue medications were used, the times and dosages are mandatory to be recorded in the diary book by the patients themselves. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02965807
Study type Interventional
Source Guangzhou Institute of Respiratory Disease
Contact yanqiuzi cheng
Phone 15915709477
Email 736145682@qq.com
Status Recruiting
Phase Phase 1/Phase 2
Start date February 2015
Completion date December 2017

See also
  Status Clinical Trial Phase
Recruiting NCT04796844 - MANI Real-life Perspective Observatory
Not yet recruiting NCT05735431 - Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil Phase 3
Terminated NCT00262652 - Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics Phase 1/Phase 2
Completed NCT02999711 - Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma Phase 1
Completed NCT05757908 - Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist N/A